loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Ferric Derisomaltose

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Ferric Derisomaltose

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 29,626Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Japan approves iron deficiency drug from Pharmacosmos
    Japan approves iron deficiency drug from Pharmacosmos

    29 Mar 2022

    // M.A. Hemmingsen MEDWATCH

    https://medwatch.com/News/Pharma___Biotech/article13868643.ece?utm_campaign=MedWatch%20Newsletter&utm_content=2022-03-28&utm_medium=email&utm_source=medwatch_com

    M.A. Hemmingsen MEDWATCH
    29 Mar 2022
    Share Share
    Monofer (ferric derisomaltose) injection is approved in China for the treatment
    Monofer (ferric derisomaltose) injection is approved in China for the treatment

    10 Feb 2021

    // FIRSTWORDPHARMA

    https://www.firstwordpharma.com/node/1799663?tsid=33

    FIRSTWORDPHARMA
    10 Feb 2021
    Share Share